Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004) - PubMed (original) (raw)
Meta-Analysis
Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004)
Jesus N Sarol Jr et al. Curr Med Res Opin. 2005 Feb.
Abstract
Objective: To determine if therapeutic management programs that include self-monitoring of blood glucose result in greater HbA1c reduction in non-insulin-requiring type 2 diabetes patients compared to programs without blood glucose self-monitoring.
Research design and methods: Electronic databases including MEDLINE (1966-2004), Cochrane Database of Systematic Reviews, EMBASE (1950-2004), Centre for Reviews and Dissemination (CRD) and the Online Index Journals of the American Diabetes Association (ADA 1978-2004) were searched. Personal collections of investigators were also explored. Randomized controlled trials comparing HbA1c reduction in therapies with and without blood glucose self-monitoring among adult, non-insulin-treated type 2 diabetes patients were selected. Studies on patients who are pregnant, taking insulin, troglitazone or experimental drugs were excluded. Out of 14 potentially useful randomized controlled trials on self-monitoring of blood glucose in non-insulin treated type 2 diabetes patients, eight studies with a total of 1307 subjects were included in the analysis. Two independent reviewers assessed the quality of studies.
Main outcome measure: The effect of SMBG was assessed by means of meta-analysis of the difference in HbA1c reduction between self-monitoring and non-self-monitoring groups.
Results: Antidiabetic therapies that included blood glucose self-monitoring as part of a multi-component management strategy produced a mean additional HbA(1c) reduction of -0.39% (95%CI: -0.54%, -0.23%) under the fixed effects model and -0.42% (95%CI: -0.63%, -0.21%) under the random effects model, when compared to therapies that did not. Heterogeneity among studies was not statistically significant.
Conclusion: Multi-component diabetes management programs with self-monitoring of blood glucose result in better glycemic control among non-insulin-using type 2 diabetes patients.
Similar articles
- Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Farmer AJ, et al. BMJ. 2012 Feb 27;344:e486. doi: 10.1136/bmj.e486. BMJ. 2012. PMID: 22371867 - Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update.
Poolsup N, Suksomboon N, Rattanasookchit S. Poolsup N, et al. Diabetes Technol Ther. 2009 Dec;11(12):775-84. doi: 10.1089/dia.2009.0091. Diabetes Technol Ther. 2009. PMID: 20001678 - A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA, Haastert B, Trautner C, Müller UA, Nauck MA, Heinemann L; Clinical Trials Study Group of the German Association for the Study of Diabetes (Deutsche Diabetes-Gesellschaft). Nauck MA, et al. Diabetologia. 2014 May;57(5):868-77. doi: 10.1007/s00125-014-3168-1. Epub 2014 Jan 21. Diabetologia. 2014. PMID: 24445534 Clinical Trial. - Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
Mannucci E, Antenore A, Giorgino F, Scavini M. Mannucci E, et al. J Diabetes Sci Technol. 2018 Jan;12(1):183-189. doi: 10.1177/1932296817719290. Epub 2017 Jul 12. J Diabetes Sci Technol. 2018. PMID: 28697625 Free PMC article. - Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial.
Nishimura A, Harashima SI, Fujita Y, Tanaka D, Wang Y, Liu Y, Inagaki N. Nishimura A, et al. J Diabetes Complications. 2017 Jan;31(1):228-233. doi: 10.1016/j.jdiacomp.2016.08.019. Epub 2016 Aug 28. J Diabetes Complications. 2017. PMID: 27653670 Clinical Trial.
Cited by
- Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes.
Heneghan C, Perera R, Ward A A, Fitzmaurice D, Meats E, Glasziou P. Heneghan C, et al. BMC Med Res Methodol. 2007 May 2;7:18. doi: 10.1186/1471-2288-7-18. BMC Med Res Methodol. 2007. PMID: 17474976 Free PMC article. - Systematic review of use of blood glucose test strips for the management of diabetes mellitus.
Canadian Agency for Drugs and Technologies in Health (CADTH). Canadian Agency for Drugs and Technologies in Health (CADTH). CADTH Technol Overv. 2010;1(2):e0101. Epub 2010 Jun 1. CADTH Technol Overv. 2010. PMID: 22977399 Free PMC article. No abstract available. - Telemedical artificial pancreas: PARIS (Pancreas Artificial Telemedico Inteligente) research project.
de Leiva A, Hernando ME; EDUAB-HSP; GBT-UPM; Rigla M, Capel I, Brugués E, Pons B, Erdozain L, Prados A, Corcoy R, Gómez EJ, García-Sáez G, Martínez-Sarriegui I, Rodríguez-Herrero A, Pérez-Gandía C, del Pozo F. de Leiva A, et al. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S211-6. doi: 10.2337/dc09-S313. Diabetes Care. 2009. PMID: 19875554 Free PMC article. No abstract available. - The dilemma of self-monitoring of blood glucose.
Davidson MB. Davidson MB. Diabetologia. 2007 Mar;50(3):497-9. doi: 10.1007/s00125-006-0582-z. Diabetologia. 2007. PMID: 17235523 No abstract available. - The impact of self-monitoring in chronic illness on healthcare utilisation: a systematic review of reviews.
McBain H, Shipley M, Newman S. McBain H, et al. BMC Health Serv Res. 2015 Dec 18;15:565. doi: 10.1186/s12913-015-1221-5. BMC Health Serv Res. 2015. PMID: 26684011 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous